EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Toward a More accurate, Evidence‐Based Classification of CYP Inhibitors: A Critical Appraisal of Current Systems

Janne T Backman iD

Clinical Pharmacology & Therapeutics · 2026

DOI: 10.1002/cpt.70122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Pharmacology & Therapeutics, 2026. Verfasst von Janne T Backman. Beteiligte Einrichtung: Department of Clinical Pharmacology, University of Helsinki, Helsinki, Finland. Hauptthemen laut MEDLINE: Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 Enzyme Inhibitors. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Sigrid Jusélius Foundation, Sigrid Juséliuksen Säätiö.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this issue of CPT, Malavé et al . deliver a comprehensive reassessment of CYP2C19 inhibitor classifications through a systematic review of clinical drug–drug interaction (DDI) studies. While their findings bring clarity to specific discrepancies, this commentary explores the origins of such inconsistencies, particularly focusing on methodological, pharmacogenetic, and substrate‐specific complexities. These issues prompt renewed consideration of how CYP inhibitor categories are defined, communicated, and used in clinical and regulatory settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cytochrome P-450 CYP2C19 InhibitorsCytochrome P-450 Enzyme InhibitorsHumansDrug InteractionsCytochrome P-450 CYP2C19Evidence-Based Medicine

Substanzen

Cytochrome P-450 CYP2C19Cytochrome P-450 CYP2C19 InhibitorsCytochrome P-450 Enzyme InhibitorsCYP2C19 protein, human

Autor:innen und Institutionen

  • Department of Clinical Pharmacology, University of Helsinki, Helsinki, Finland.
  • Individualized Drug Therapy Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Department of Clinical Pharmacology, HUS Diagnostic Center, Helsinki University Hospital, Helsinki, Finland.

ORCID-Profile: Janne T Backman

Förderung

  • Sigrid Jusélius Foundation
  • Sigrid Juséliuksen Säätiö

Zitieren

APA

Backman, J. T. (2026). Toward a More accurate, Evidence‐Based Classification of CYP Inhibitors: A Critical Appraisal of Current Systems. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.70122

Vancouver

Backman JT. Toward a More accurate, Evidence‐Based Classification of CYP Inhibitors: A Critical Appraisal of Current Systems. Clinical Pharmacology & Therapeutics. 2026. doi:10.1002/cpt.70122

BibTeX
@article{Backman2026,
  author = {Backman, Janne T},
  title = {Toward a More accurate, Evidence‐Based Classification of CYP Inhibitors: A Critical Appraisal of Current Systems},
  journal = {Clinical Pharmacology & Therapeutics},
  year = {2026},
  doi = {10.1002/cpt.70122}
}
Kostenlos starten →